» Articles » PMID: 38464870

[HEARTS in the Americas: Targeting Health System Change to Improve Population Hypertension ControlHEARTS Nas Américas: Impulsionar Mudanças No Sistema De Saúde Para Melhorar O Controle Da Hipertensão Arterial Na População]

Abstract

Purpose Of Review: HEARTS in the Americas is the regional adaptation of Global Hearts, the World Health Organization initiative for cardiovascular disease (CVD) prevention and control. Its overarching goal is to drive health services to change managerial and clinical practice in primary care settings to improve hypertension control and CVD risk management. This review describes the HEARTS in the Americas initiative. First, the regional epidemiological situation of CVD mortality and population hypertension control trends are summarized; then the rationale for its main intervention components: the primary care-oriented management system and the HEARTS Clinical Pathway are described. Finally, the key factors for accelerating the expansion of HEARTS are examined: medicines, team-based care, and a system for monitoring and evaluation.

Recent Findings: Thus far, 33 countries in Latin America and the Caribbean have committed to integrating this program across their primary healthcare network by 2025. The increase in hypertension coverage and control in primary health care settings compared with the traditional model is promising and confirms that the interventions under the HEARTS umbrella are feasible and acceptable to communities, patients, providers, decision-makers, and funders. This review highlights some cases of successful implementation.

Summary: Scaling up effective treatment for hypertension and optimization of CVD risk management is a pragmatic way to accelerate the reduction of CVD mortality while strengthening primary healthcare systems to respond effectively, with quality, and equitably, to the challenge of non-communicable diseases, not only in low-middle income countries but in all communities globally.

References
1.
Barake F, Paccot M, Rivera M, Neira C, Reyes V, Escobar M . Chile's public healthcare sector hypertension control rates before and during the pandemic and HEARTS implementation. Rev Panam Salud Publica. 2022; 46:e126. PMC: 9440732. DOI: 10.26633/RPSP.2022.126. View

2.
Al-Makki A, DiPette D, Whelton P, Murad M, Mustafa R, Acharya S . Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary. Hypertension. 2021; 79(1):293-301. PMC: 8654104. DOI: 10.1161/HYPERTENSIONAHA.121.18192. View

3.
Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A . 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal.... J Hypertens. 2023; 41(12):1874-2071. DOI: 10.1097/HJH.0000000000003480. View

4.
Lloyd-Sherlock P, Ebrahim S, Martinez R, Mckee M, Ordunez P . Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000-15. Lancet Glob Health. 2019; 7(5):e604-e612. DOI: 10.1016/S2214-109X(19)30069-5. View

5.
Prado P, Gamarra A, Rodriguez L, Brettler J, Farrell M, Girola M . [Monitoring and evaluation platform for HEARTS in the Americas: improving population-based hypertension control programs in primary health carePlataforma de monitoramento e avaliação do programa HEARTS nas Américas: melhoria dos programas de...]. Rev Panam Salud Publica. 2023; 47:e90. PMC: 10202337. DOI: 10.26633/RPSP.2023.90. View